Page 37 - Expanded Access Program News Today : Breaking News, Live Updates & Top Stories | Vimarsana

RedHill Biopharma Ltd Announces RedHill s RHB-102 Positive MHRA Meeting & MAA Plan

RedHill Biopharma Ltd Announces RedHill s RHB-102 Positive MHRA Meeting & MAA Plan
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United kingdomUnited statesCity ofRedhill biopharmaAdi frishLondon stock exchangeFinancial conduct authorityRedhill biopharma ltdRegulatory agencyExchange commissionCompany annual report on formCompany expanded access programCompany report on formCorporate business developmentKingdom marketing authorisation applicationMarketing authorisation application

RedHill Biopharma (RDHL) Announces RedHill s RHB-102 Positive MHRA Meeting & MAA Plan

RedHill Biopharma (RDHL) Announces RedHill s RHB-102 Positive MHRA Meeting & MAA Plan
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Albireo Pharma (ALBO) Announces FDA Grants June 15, 2023 PDUFA Date to Albireo for Bylvay in Alagille Syndrome

Albireo Pharma (ALBO) Announces FDA Grants June 15, 2023 PDUFA Date to Albireo for Bylvay in Alagille Syndrome
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesAsia pacificRon cooperRoberta smithAlbireo pharma incTanner pharma groupDrug administrationAlagille syndrome allianceAccess programWall streetNew drug applicationPrescription drug user fee actPriority reviewChief executive officerOrphan designationLiver meeting

Seelos Therapeutics Announces Completion of Enrollment of its Phase II/III Trial of SLS-005 in Amyotrophic Lateral Sclerosis on the HEALEY ALS Platform

Seelos Therapeutics Announces Completion of Enrollment of its Phase II/III Trial of SLS-005 in Amyotrophic Lateral Sclerosis on the HEALEY ALS Platform
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

New yorkUnited statesLou gehrigAnthony marcianochief communications officerseelos therapeutics incHuman servicesPartnership for rare neurodegenerative diseasesNational institutes of healthMike moyermanaging directorlifesci advisorsSeelos therapeutics incDrug administrationExchange commissionDepartment of healthEuropean medicines agencyNational institute of neurological disordersAccess programExpanded access program

BioVentrix® Names Dr Ori Ben-Yehuda as Chief Medical Officer

/PRNewswire/ BioVentrix®, Inc., a privately held medical device company focused on the development of less invasive therapies to directly treat the dilated.

United statesSan diegoJim dillonUniversity of californiaInvestigational useGilead sciencesDrug administrationJournal of the heart teamPatient care experience to senior management teamBioventrix incDepartment of medicine teachingClinical trials centerCardiovascular research foundationAccess programBrings extensive clinical trialPatient care experience